Extended Release Tacrolimus vs. Twice-Daily Tacrolimus

NCT03289650 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

End Stage Renal Disease
Rejection of Renal Transplant

Interventions

DRUG: Tacrolimus
DRUG: Tacrolimus Extended Release Oral Tablet [Envarsus]

Sponsor

Lorenzo Gallon